Work

Safety and Efficacy of Venetoclax Plus Low-Dose Cytarabine in Treatment-Naive Patients Aged ≥65 Years with Acute Myeloid Leukemia

Year: 2016

Type: article

Source: Blood

DOI: 10.1182/blood.v128.22.102.102

Authors: Andrew Wei, Stephen A. Strickland, Gail J. Roboz, Jing-Zhou Hou, Walter Fiedler, Tara L. Lin, Giovanni Martinelli, Roland B. Walter, Anoop Enjeti, Kaffa Fakouhi, David E. Darden, Martin Dunbar, Ming Zhu, Suresh Agarwal, Ahmed H. Salem, Mack Mabry, John Hayslip

Institutions: The Alfred Hospital, Monash University, Vanderbilt University, Vanderbilt-Ingram Cancer Center, NewYork–Presbyterian Hospital, Weill Cornell Medicine, Weill Cornell Medical Center, UPMC Hillman Cancer Center, University of Pittsburgh Medical Center, University Medical Center Hamburg-Eppendorf, The University of Kansas Cancer Center, University of Bologna, University of Washington, Fred Hutch Cancer Center, Calvary Mater Newcastle Hospital, AbbVie (United States)

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2579079821

FWCI: 10.29

Cites:

Cited by: 45

Related to: 10